Department of Medicine – Med/Cardiovascular Medicine
Fátima Rodriguez, MD, MPH is a practicing general and preventive cardiologist and a health disparities researcher. Dr. Rodriguez attended the University of Pennsylvania, where she graduated summa cum laude with a degree in the Biological Basis of Behavior. Prior to medical school, she worked as a certified Spanish medical interpreter in Philadelphia hospitals. She then received her medical degree from Harvard Medical School and her MPH from the Harvard School of Public Health as a Zuckerman Fellow from the Harvard Kennedy School’s Center for Public Leadership. She completed internal medicine residency at Brigham and Women’s Hospital and Harvard University.
Dr. Rodriguez arrived to Stanford University in 2014 as a cardiovascular medicine fellow and was selected to serve as Chief Fellow. Her research interests include a range of issues relating to racial and ethnic disparities in guideline adherence, cardiovascular disease prevention, health promotion and leveraging technology to improve the care of diverse patients. She has authored over 70 peer-reviewed publications on these topics and has been a two-time winner of Stanford University’s Alderman Award for Excellence in Clinical Research. Her work is funded by a career development award from the National Heart, Lung, and Blood Institute and the McCormick Galiban Faculty Award. Dr. Rodriguez is the Research Director for an innovative telemedicine program in cardiology, CardioClick, and Director of Population Health for Stanford’s Systems Utilization Research. As a Fellow of the American College of Cardiology and the American Heart Association, she holds multiple leadership roles aimed at improving gender and racial/ethnic diversity in cardiology. Dr. Rodriguez serves as an Associate Editor for the New England Journal of Medicine Journal Watch Cardiology.
SAGE Project: Secondary prevention of cardiovascular disease in the elderly
Dr. Rodriguez’s project will study the current practice patterns for low-density lipoprotein cholesterol (LDL-C) lowering among adults over 75 years of age in a large multiethnic electronic health record-based cohort. The current American College of Cardiology/American Heart Association guidelines on management of blood cholesterol explicitly note the lack of data for the benefit of intensive lipid-lowering among older adults, who have not been included in the clinical trials that guide our evidence base. Dr. Rodriguez will also identify patient-level predictors of moderate and high-intensity statin use among high risk patients with atherosclerotic cardiovascular disease.